Josephine Ninsiima, Technical Advisor at METS at the 30th Conference on Retroviruses and Opportunistic Infections (CROI) held February 19-22, 2023 - Seattle, Washington, USA. Photo: METS
The Monitoring and Evaluation Technical Support (METS) Program is a 5-year CDC-supported collaboration of Makerere UniversitySchool of Public Health (MakSPH), the University of California San Francisco (UCSF) and Health Information Systems Program (HISP Uganda).
Highlights of the METS July 2023 Newsletter
30th Conference on Retroviruses and Opportunistic Infections (CROI)
Josephine Ninsiima, a Technical Advisor at METS, attended CROI and made a presentation on the ‘Implications of Cervical Cancer Screening and Treatment Program Roll Out in Uganda’. METS performed a retrospective analysis of CxCa screening and care cascade data for a period of 18 months (October 2020 to March 2022).
Key findings included: Up to 6% of WLHIV screened positive for CxCa precancerous lesions
Among those found positive, linkage to treatment increased gradually to 75% for October 2021–March 2022 compared to 54% for October 2020–September 2021.
15th AIDS Impact Conference
During the 15th AIDS Impact Conference held in 12th – 14th June 2023 in Stockholm, Sweden, METS presented the results of a pilot integration study that demonstrated that combining services for HIV and other health conditions can work well to provide an all-round care package to patients, where health providers are equipped with the right support and training. For example, the study found that training healthcare ‘teams’ helped improve the quality of cervical cancer services.
DHIS2 Conference in Norway and Tanzania
METS, a Data Science and Informatics Implementing partner to the Ministry of Health (MoH), had the privilege of participating in the DHIS2 Annual Conference in Norway and the DHIS2 Tracker Configuration Academy in Tanzania.
DHIS2 is an open-source, web-based health management information system (HMIS) platform. In Uganda, DHIS2 serves as the foundation for eHMIS, acting as the central database for aggregated public health statistics since 2012.
It plays a vital role in reporting health data to regional and international stakeholders and facilitates mobile health data collection via SMS and smartphones. Additionally, DHIS2 enables the longitudinal tracking of patients enrolled in specific healthcare programs.
Uganda Data Science, Surveillance, and Informatics CDC Uganda – CDC HQ Technical Exchange
METS was part of a technical exchange visit between Centers for Disease Control and Prevention (CDC) and the Uganda Ministry of Health (MoH) in the areas of data science, health information systems and informatics that was held in Atlanta, USA.
The meeting reviewed available infrastructure and systems, ways of building capacity of public health workforce to enable digital transformation and discussed partnerships to foster international coordination and global data networks in support of systems and programs that facilitate data sharing and decision making.
2023 OpenHIE Community Meeting
The meeting held 1st – 5th May 2023 in Lilongwe, Malawi aimed to advance OpenHIE (Open Health Information Exchange) and promote country-owned and driven health information sharing architectures. It served as a platform to showcase strategies for sustainable and standards-based sharing of health information to improve health outcomes.
Attendees included software developers, implementers, and government officials from over 33 countries who included METS’ Samuel Lubwama, Simon Peter Muwanguzi, Edward Bichetero and Evelyn Akello.
Gallery
DHIS2 Conference in Oslo, Norway and Dar-es-Salaam, Tanzania
OpenHIE Meeting
4th of July celebrations at the US Embassy Kampala
15th AIDS Impact Conference
30th Conference on Retroviruses and Opportunistic Infections (CROI)
The Sanger Prize presents a wonderful opportunity for genomics students in low and middle income countries, therefore the prize administrators are keen for the application information to reach as many eligible people as possible.
The MPhil in Genomic Science is a 1-year research MPhil, registered at the University of Cambridge and based at the Wellcome Sanger Institute, Hinxton, UK.
The Wellcome Sanger Institute is a world leading genomics institute at the forefront of experimental, computational and translational genomic research and the programme aims to equip students from our partner institutions with a unique blend of experimental and informatics skills, maximising their competitiveness for future opportunities.
See downloads for detailed application information.
A Voice for Excellence, Equity and African Sovereignty
When Dr. Michael Makanga walked onto the stage at the 8th Galien Forum Africa in Dakar on 31 October 2025 to receive the Special Career Achievement Galien Prize, presented by President Bassirou Diomaye Faye under the theme Health sovereignty: an imperative for Africa, the moment carried weight beyond any medal or citation. “It is a celebration of a lifelong commitment,” he said, “but also a reminder of a responsibility I have never been willing to compromise: to inspire others to raise their voices for excellence, science, and equity.”
For more than two decades, Dr. Makanga has been a quiet architect of Africa’s health sovereignty. His work has unfolded far from cameras: in laboratories constrained by resources, in policy rooms where African priorities demanded a stronger voice, and in mentoring sessions with young scientists seeking reassurance that their ideas mattered.
Born and trained in Uganda, Dr. Makanga earned a Bachelor of Medicine and Surgery from Makerere University before pursuing a master’s degree and PhD at the Liverpool School of Tropical Medicine. His career spans nearly 30 years, encompassing tropical medicine, clinical trials in Africa and Europe, and senior international management roles. Since joining EDCTP in 2004, he has guided its growth as a unique Africa–Europe partnership, strengthening African capacity for high-quality, ethical clinical research while accelerating solutions for poverty-related diseases. Today, he leads the Global Health EDCTP3 Joint Undertaking under the EU’s Horizon Europe programme.
President Faye captured the essence of Dr. Makanga’s achievement: “Scientific excellence is not negotiable; it is earned. It underpins our credibility and our sovereignty.” For Dr. Makanga, the statement is a call to action. “I hope this recognition reminds us that Africa’s scientists and innovators can lead global health research with excellence and purpose. We owe it to the next generation to build the systems and confidence that make this possible,” he said.
Dr. Makanga’s peers describe him as a “builder”: someone who strengthens research systems, mentors emerging scientists, and fosters equitable partnerships long before “local ownership” became a policy buzzword. In his own words, the award honors his “career’s contribution to advancing Africa’s health sovereignty” while reinforcing his commitment to ensure younger scientists do not have to fight for legitimacy as previous generations did.
The 2025 Prix Galien Africa celebrated Dr. Makanga alongside innovators reshaping African science. La Ruche Health, a Côte d’Ivoire-based digital health platform, won for connecting users to certified providers through an AI-powered system. Senegalese computer scientist Adji Bousso Dieng received a special prize for applying artificial intelligence to the natural sciences, including spotting emerging viral variants using her “Vendi Score” tool. The awards were organised with the support of the Presidency of Senegal, the Gates Foundation, the West African Health Organization, and the Rockefeller Foundation, with a jury co-chaired by Dr. John Nkengasong and Professor Souleymane Mboup.
Yet the award’s true weight lies not in ceremony, but in its symbolism. Dr. Makanga’s career exemplifies how African scientists can lead, shape policy, and influence global health priorities when empowered and supported.
L-R: La Ruche Health (Côte d’Ivoire) innovator, President of Senegal, Bassirou Diomaye Faye, Dr Michael Makanga (Uganda) and Adji Bousso Dieng (Senegal)
Makerere University colleagues attest to this impact. Dr. Victoria Nankabirwa, a clinical researcher and epidemiologist, reflects: “EDCTP support allowed me to build multidisciplinary teams, enhance laboratory and trial infrastructure, and generate evidence relevant for policy and practice. It strengthened my scientific independence and expanded the long-term sustainability of my research, particularly on childhood vaccines.”
She adds, “Dr. Makanga’s vision and commitment have strengthened institutions, built capacity, and fostered equitable partnerships, enabling African investigators to lead complex studies that address the continent’s priorities. His recognition shows what is possible when scientists are empowered, trusted, and supported.”
Dr. Alex Kayongo, an immunologist at Makerere University, describes EDCTP support as “catalytic,” enabling advanced training and a platform to study microbiome–immune interactions in HIV-associated COPD. His work is shaping mechanistic insights and strengthening Uganda’s capacity for complex respiratory immunology research. “Global health funding is increasingly competitive, making EDCTP’s role even more vital,” he says. “Africa needs sustainable support for complex, lab-intensive research. Continued investment in infrastructure, leadership, and fair partnerships is essential if African institutions are to drive innovation and secure true scientific sovereignty.”
Dr. David Musoke, an associate professor of disease control, credits his EDCTP fellowship with deepening his malaria research and advancing his career. His studies combined housing improvements, environmental management, and behavioural measures to complement traditional malaria prevention, shaping practical, community-informed interventions. “Dr. Makanga’s contribution to African science has been tremendous, and his continued stewardship gives us confidence that evidence generated on the continent will increasingly shape policy and practice,” he observes.
Dr. Makanga’s impact is visible not only in individual careers but across institutions and nations. Through EDCTP, he has championed African-led trials, strengthened laboratory capacity, and fostered cross-country collaboration. Colleagues emphasize that his leadership has created a generation of African scientists who are confident, collaborative, and globally competitive.
“My experience with EDCTP-funded programmes has shown the transformative impact of African-led research,” Dr. Nankabirwa reflects. “Dr. Makanga’s vision and commitment have strengthened institutions, built capacity, and fostered equitable partnerships, enabling African investigators to lead complex studies that address the continent’s priorities. His recognition shows what is possible when scientists are empowered, trusted, and supported, inspiring the next generation of research leaders.”
Dr. Makanga’s recognition is a tribute to perseverance, vision, and mentorship: a scientist who kept going when resources were scarce, a leader who refused partnerships that treated Africans as subjects, and a mentor who reminded young researchers that they belong at the centre of global science.
As he stood among Africa’s leading innovators in Dakar, the message was unmistakable: Africa can lead, Africa must lead, and it will lead, through science, excellence, and equity.
Makerere University is proud to celebrate Dr. Michael Makanga, one of its distinguished alumni, on receiving the Special Career Achievement Prize of the Prix Galien Africa 2025. This honor recognises his exceptional leadership in medical research and his role in advancing African-led science. Through his work, Dr. Makanga continues to strengthen institutions, mentor emerging researchers, and amplify Africa’s voice on the global health stage.